Bone Microarchitectural Database Constitution From HR-pQCT Device in Clinical Situation Potentially Associated With Bone Loss (DMPOs)
Osteoporosis, Bone Loss
About this trial
This is an interventional diagnostic trial for Osteoporosis focused on measuring fracture osteoporosis, bone microarchitecture, Inflammatory joint diseases, Bone fragility, Rheumatoid Arthritis, Spondyloarthritis, Primary Hyperparathyroidism, constitutional thinness, anorexia nervosa
Eligibility Criteria
Inclusion Criteria:
For patients:
1.1.Women or Men taken in charge in Saint-Etienne' Hospital and one of the following pathologies: 1.1-a : Osteoporosis defined as: history of fracture by bone fragility documented 1.1-b : Bone Fragility: Patient with the indication of bone densitometry without a fracture history 1.1-c Articular inflammatory disease: Rheumatoid Arthritis, Spondyloarthritis 1.1-d Endocrine diseases : Primary Hyperparathyroidism, Constitutional Thinness, Anorexia nervosa 1.2. written consent
- For controls:
2.1. Episode of acute back pain or radicular pain (lasting for less than a month) with taking corticosteroid less than 1 month 2.2. written consent
Exclusion Criteria:
drugs induced bone loss: 1.1.Anti-aromasine or GnRH agonist for at least 6 months, 1.2. Corticosteroid therapy 1.3. Antiepileptic carbamazepine, phenobarbital, phenytoin, primidone, valproic acid for at least 6 months) 2. fracture due to bone fragility 3. drug with bone effect (bisphosphonate, teriparatide, strontium ranelate)
Sites / Locations
- Chu Saint-EtienneRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Patient group
control group
Measure bone quality and quantity with HR-pQCT, pQCT and DEXA of patient group Patient group is patient with one of the following pathology : Osteoporosis, Bone Fragility, articular inflammatory disease or Endocrine diseases
Measure bone quality and quantity with HR-pQCT, pQCT and DEXA of control group. Patient group is patient with episode of acute back pain or radicular pain